Mika K Derynck
Director · 2 filings · Latest: Aug 4, 2026
Enliven Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
ELVN | Mika K Derynck | Director | Aug 4, 2026 | Sale | $60.21 | 158,795 | $9.6M | 0 | |
ELVN | Mika K Derynck | Director | Aug 4, 2026 | Option Exercise | $10.84 | 158,795 | $1.7M | 158,795 | |
ELVN | Derynck Mika K | — | Aug 4, 2026 | Proposed Sale | $58.04 | 158,795 | $9.2M | — | |